Exploring Drugs of Abuse and Transgenerational Phenotypes (R01) | Apply Online

Opportunity Summary:

Exploring Drugs of Abuse and Transgenerational Phenotypes (R01) is a National Institutes of Health (NIH) research grant opportunity that was designed to fund studies testing whether exposure to drugs of abuse can produce measurable effects that persist into later generations. The central scientific question behind the funding opportunity is whether drug exposure in one generation (for example, before conception, during pregnancy, or during other sensitive developmental windows) can be associated with behavioral, molecular, physiological, or other observable phenotypes in offspring and even subsequent generations. In practical terms, the program is aimed at research that moves beyond immediate, first-generation outcomes and instead investigates multi-generational or transgenerational consequences, potentially including changes in brain and behavior, altered stress responsivity, differences in disease vulnerability, or biological signatures that track across generations.

The funding mechanism is an R01, meaning it supports substantial, hypothesis-driven research projects that typically involve a well-developed experimental plan, clear aims, and rigorous methods. As an NIH discretionary grant in the health and education activity area, it aligns with the NIH mission of advancing biomedical and behavioral science, and it falls under CFDA 93.279 (Drug Abuse and Addiction Research Programs). The announcement explicitly indicates that cost sharing or matching is not required, which generally lowers the administrative and financial barriers for applicants and keeps the emphasis on scientific merit and feasibility rather than institutional cost contributions.

Eligibility for this opportunity was broad and inclusive, reflecting NIH practice of encouraging a wide range of organizations to propose strong research programs. Eligible applicants included public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status, as long as they were not institutions of higher education in the non-501(c)(3) category), for-profit organizations other than small businesses, small businesses, and multiple levels of government entities (state, county, city/township, special district governments, and independent school districts). The eligibility language also covered tribal governments and tribal organizations, public housing authorities/Indian housing authorities, and a variety of mission-specific institution types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and faith-based or community-based organizations. Importantly, the FOA allowed participation by non-U.S. entities (foreign organizations), regional organizations, U.S. territories or possessions, and foreign components of U.S. organizations, which signals an openness to global expertise and international study populations or models where scientifically justified.

From an administrative standpoint, the opportunity was posted and created on March 17, 2011, with an application closing date of July 29, 2011, and an archive date of August 29, 2011, meaning it was a time-limited call rather than an open-ended standing program announcement. The official full announcement was hosted through the NIH grants guide (RFA-DA-12-006), and support contacts were routed through the NIH Office of Extramural Research (OER) webmaster for access or linking issues. Overall, this FOA can be understood as a targeted NIH effort to stimulate rigorous research on whether drugs of abuse can leave a biological or behavioral imprint that extends beyond the directly exposed individual, with implications for understanding addiction risk, developmental trajectories, and the long-term public health impact of substance exposure across generations.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Biomarkers of Infection Associated Cancers (R01)

Previous opportunity: Evidence to Action for Strengthened Family Planning and Reproductive Health Services for Women and Girls (E2A)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 12 006

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 12 006) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 12 006", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.